Skip to content

Feed Screener Search Methodology

SEC · FI · BAFIN · AFM · AMF

Pricing Sign in

InsiderLens

Statistics predict. AI explains.

Insider transactions from public regulatory disclosures, aggregated and enriched with deterministic statistical signals. Not investment advice.

Sources

SEC EDGAR · US
FINANSINSPEKTIONEN · SE
BAFIN · DE
AFM · NL
AMF · FR

Product

Methodology
Privacy notice
Object to processing

Feed Screener Search Methodology

Pricing Sign in

Buschle Michael — Y-mAbs Therapeutics, Inc. insider · InsiderLens

Home / Insiders / Buschle Michael

Buschle Michael

Director at Y-mAbs Therapeutics, Inc. · on record since Sep 20, 2018

Insider trading activity of Buschle Michael

No transactions on record for Buschle Michael.

Track record of Buschle Michael

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Buschle Michael

Co-insiders of Buschle Michael

Ahmed MahiuddinY-mAbs Therapeutics, Inc.
Ber GerardY-mAbs Therapeutics, Inc.
Gad ThomasY-mAbs Therapeutics, Inc.
Gentilcore Douglas JY-mAbs Therapeutics, Inc.
GILL DAVID NY-mAbs Therapeutics, Inc.
Hamill LauraY-mAbs Therapeutics, Inc.
HEALY JAMESY-mAbs Therapeutics, Inc.
Herman Philip KarlY-mAbs Therapeutics, Inc.
Juan Moller San Pedro ClausY-mAbs Therapeutics, Inc.
Kruse BoY-mAbs Therapeutics, Inc.
LaRocca JohnY-mAbs Therapeutics, Inc.
Lisby SteenY-mAbs Therapeutics, Inc.
Lund-Hansen TorbenY-mAbs Therapeutics, Inc.
PFREUNDSCHUH PETER P.Y-mAbs Therapeutics, Inc.
Rajah VigneshY-mAbs Therapeutics, Inc.
Raskin Gregory SY-mAbs Therapeutics, Inc.
Rossi Michael JY-mAbs Therapeutics, Inc.
Smith Susan LauraY-mAbs Therapeutics, Inc.
TAGLIAFERRI MARYY-mAbs Therapeutics, Inc.
TYAGI ASHUY-mAbs Therapeutics, Inc.
Wedell-Wedellsborg JohanY-mAbs Therapeutics, Inc.
WG Biotech ApSY-mAbs Therapeutics, Inc.
Wilms JorisY-mAbs Therapeutics, Inc.

This page republishes public regulatory disclosures. Concerned by this data? Exercise your right to object →

No transactions on record. Reset filters